Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia

NCT03230071 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Vascular Dementia

Interventions

DRUG: TMBCZG
OTHER: placebo

Sponsor

Dongzhimen Hospital, Beijing

Collaborators

[object Object]
[object Object]